Publications
Download CSV
Download XLSX
Download TXT
Tables
2025 (2)
2024 (76)
2023 (190)
2022 (232)
2021 (262)
2020 (169)
2019 (155)
2018 (573)
2017 (782)
2016 (747)
2015 (638)
2014 (582)
2013 (460)
2012 (330)
2011 (191)
2010 (67)
2009 (38)
2008 (38)
2007 (13)
2006 (19)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (5579)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Eriksson O
JSON
CSV
XLSX
TXT
Family name
Eriksson
Given name
Olof
Initials
O
ORCID
ORCID
0000-0002-2515-8790
Affiliations
17 publications
PubMed
DOI
Crossref
[18F]MK-7246 for Positron Emission Tomography Imaging of the Beta-Cell Surface Marker GPR44.
Cheung P
, Amin MA,
Zhang B
, ..., Odell LR,
Eriksson O
Pharmaceutics
15
(2) - [2023-02-02; online 2023-02-02]
Olof Eriksson
SciLifeLab Fellow
PubMed
DOI
Crossref
Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences.
Velikyan I
, Bossart M, Haack T, ..., Wagner M,
Eriksson O
Pharmaceuticals (Basel, Switzerland)
16
(1) - [2022-12-31; online 2022-12-31]
Olof Eriksson
SciLifeLab Fellow
PubMed
DOI
Crossref
PET-CT imaging of pulmonary inflammation using [68Ga]Ga-DOTA-TATE.
Puuvuori E, Liggieri F, Velikyan I, ..., Perchiazzi G,
Eriksson O
EJNMMI Res
12
(1) 19 [2022-04-08; online 2022-04-08]
Olof Eriksson
SciLifeLab Fellow
PubMed
DOI
Crossref
The Current State of Beta-Cell-Mass PET Imaging for Diabetes Research and Therapies.
Cheung P
,
Eriksson O
Biomedicines
9
(12) - [2021-12-03; online 2021-12-03]
Olof Eriksson
SciLifeLab Fellow
PubMed
DOI
Crossref
Improved Radiolytic Stability of a 68Ga-labelled Collagelin Analogue for the Imaging of Fibrosis.
Velikyan I
,
Rosenström U
, Rosestedt M,
Eriksson O
, Antoni G
Pharmaceuticals (Basel, Switzerland)
14
(10) - [2021-09-28; online 2021-09-28]
Olof Eriksson
SciLifeLab Fellow
PubMed
DOI
Crossref
Recent Progress in the Molecular Imaging of Nonalcoholic Fatty Liver Disease.
Wegrzyniak O, Rosestedt M,
Eriksson O
Int J Mol Sci
22
(14) - [2021-07-08; online 2021-07-08]
Olof Eriksson
SciLifeLab Fellow
PubMed
DOI
Crossref
Drug Occupancy Assessment at the Glucose-Dependent Insulinotropic Polypeptide Receptor by Positron Emission Tomography.
Eriksson O,
Velikyan I
, Haack T, ..., Pierrou S, Wagner M
Diabetes
70
(4) 842-853 [2021-04-00; online 2021-02-05]
Olof Eriksson
SciLifeLab Fellow
PubMed
DOI
Crossref
Longitudinal Assessment of 11C-5-Hydroxytryptophan Uptake in Pancreas After Debut of Type 1 Diabetes.
Espes D
,
Carlsson PO
, Selvaraju RK, ...,
Korsgren O
,
Eriksson O
Diabetes
70
(4) 966-975 [2021-04-00; online 2021-01-21]
Olof Eriksson
SciLifeLab Fellow
PubMed
DOI
Crossref
Exploring the GLP-1-GLP-1R axis in porcine pancreas and gastrointestinal tract in vivo by ex vivo autoradiography.
Manell E
, Puuvuori E, Svensson A, ..., Jensen Waern M,
Eriksson O
BMJ Open Diabetes Res Care
9
(1) - [2021-04-00; online 2021-04-28]
Olof Eriksson
SciLifeLab Fellow
PubMed
DOI
Crossref
Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes.
Eriksson O
, Haack T, Hijazi Y, ..., Wagner M, Tillner J
Sci Rep
10
(1) 16758 [2020-10-07; online 2020-10-07]
Olof Eriksson
SciLifeLab Fellow
PubMed
DOI
Crossref
Assessment of glucagon receptor occupancy by Positron Emission Tomography in non-human primates.
Eriksson O
, Velikyan I, Haack T, ..., Pierrou S, Wagner M
Sci Rep
9
(1) 14960 [2019-10-18; online 2019-10-18]
Olof Eriksson
SciLifeLab Fellow
PubMed
DOI
Crossref
Pancreatic perfusion and its response to glucose as measured by simultaneous PET/MRI.
Espes D, Manell E, Rydén A, ..., Jansson L,
Eriksson O
Acta diabetologica
56
(10) 1113-1120 [2019-10-00; online 2019-04-26]
Olof Eriksson
SciLifeLab Fellow
PubMed
DOI
Crossref
Synthesis and preclinical evaluation of the CRTH2 antagonist [11C]MK-7246 as a novel PET tracer and potential surrogate marker for pancreatic beta-cell mass.
Eriksson J, Roy T, Sawadjoon S, ...,
Eriksson O
, Odell LR
Nucl. Med. Biol.
71
(-) 1-10 [2019-04-00; online 2019-04-13]
Olof Eriksson
SciLifeLab Fellow
PubMed
DOI
Crossref
First-in-class positron emission tomography tracer for the glucagon receptor.
Velikyan I, Haack T, Bossart M, ..., Wagner M,
Eriksson O
EJNMMI Res
9
(1) 17 [2019-02-15; online 2019-02-15]
Olof Eriksson
SciLifeLab Fellow
PubMed
DOI
Crossref
Transplantation of macroencapsulated human islets within the bioartificial pancreas βAir to patients with type 1 diabetes mellitus.
Carlsson PO, Espes D,
Sedigh A
, ..., Olerud J, Korsgren O
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
18
(7) 1735-1744 [2018-07-00; online 2018-02-02]
Olof Eriksson
SciLifeLab Fellow
PubMed
DOI
Crossref
Cannabinoid Type 1 Receptors Are Upregulated During Acute Activation of Brown Adipose Tissue.
Lahesmaa M,
Eriksson O
, Gnad T, ..., Virtanen KA,
Nuutila P
Diabetes
67
(7) 1226-1236 [2018-07-00; online 2018-04-12]
Olof Eriksson
SciLifeLab Fellow
PubMed
DOI
Crossref
In Vivo Visualization of β-Cells by Targeting of GPR44.
Eriksson O
, Johnström P, Cselenyi Z, ..., Skrtic S,
Korsgren O
Diabetes
67
(2) 182-192 [2018-02-00; online 2017-12-05]
Olof Eriksson
SciLifeLab Fellow
SciLifeLab Data Centre
Publications
9.5.1